ClinicalTrials.Veeva

Menu

Patient Reported Outcomes With WaveLight Plus LASIK

M

Mann Eye Institute

Status

Enrolling

Conditions

Myopia
Astigmatism

Treatments

Device: WaveLigh Plus LASIK

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07084844
PB-25-02

Details and patient eligibility

About

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.

Enrollment

52 estimated patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between the ages of 18 and 39

  • Meet the standard care requirements for LASIK

  • Spherical equivalent (SE) more than -1.00D and up to -9.00 diopters

  • Myopia ≤ -8.00 sphere (in minus cylinder format) and up to -3.00D astigmatism

  • SE difference between the manifest refraction and the Sightmap measured SE being less than 0.75D

  • Minimum residual stromal bed thickness of 250 µm

  • If currently wearing contact lenses:

    • Soft CTL wearers discontinue for minimum 3 days
    • RGP CTL wearers discontinue for 1 month per decade of wear
  • Stable refraction (2 consecutive manifest refractions within 0.25 SE)

  • Stable K readings (2 consecutive K readings in 2 consecutive visits)

  • Willing and able to complete all post-operative visits

  • Pre-surgery BCDVA of 20/20 (0.00 logMAR) or better in each eye.Mesopic pupil size ≥ 4.5mm

Exclusion criteria

  • Subjects with any prior ocular surgery
  • Subjects with topographic evidence of keratoconus, or ectasia
  • Subjects with autoimmune diseases
  • Subjects who are pregnant or nursing
  • Systemic disease likely to affect wound healing, such as diabetes and severe atopy
  • Any ocular disease (including un-controlled dry eye) which in the investigator's opinion would affect the outcome of refractive surgery

Trial contacts and locations

1

Loading...

Central trial contact

Study Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems